Worthington, A.; Kalteniece, A.; Ferdousi, M.; D’Onofrio, L.; Dhage, S.; Azmi, S.; Adamson, C.; Hamdy, S.; Malik, R.A.; Calcutt, N.A.;
et al. Optimal Utility of H-Reflex RDD as a Biomarker of Spinal Disinhibition in Painful and Painless Diabetic Neuropathy. Diagnostics 2021, 11, 1247.
https://doi.org/10.3390/diagnostics11071247
AMA Style
Worthington A, Kalteniece A, Ferdousi M, D’Onofrio L, Dhage S, Azmi S, Adamson C, Hamdy S, Malik RA, Calcutt NA,
et al. Optimal Utility of H-Reflex RDD as a Biomarker of Spinal Disinhibition in Painful and Painless Diabetic Neuropathy. Diagnostics. 2021; 11(7):1247.
https://doi.org/10.3390/diagnostics11071247
Chicago/Turabian Style
Worthington, Anne, Alise Kalteniece, Maryam Ferdousi, Luca D’Onofrio, Shaishav Dhage, Shazli Azmi, Clare Adamson, Shaheen Hamdy, Rayaz A. Malik, Nigel A. Calcutt,
and et al. 2021. "Optimal Utility of H-Reflex RDD as a Biomarker of Spinal Disinhibition in Painful and Painless Diabetic Neuropathy" Diagnostics 11, no. 7: 1247.
https://doi.org/10.3390/diagnostics11071247
APA Style
Worthington, A., Kalteniece, A., Ferdousi, M., D’Onofrio, L., Dhage, S., Azmi, S., Adamson, C., Hamdy, S., Malik, R. A., Calcutt, N. A., & Marshall, A. G.
(2021). Optimal Utility of H-Reflex RDD as a Biomarker of Spinal Disinhibition in Painful and Painless Diabetic Neuropathy. Diagnostics, 11(7), 1247.
https://doi.org/10.3390/diagnostics11071247